This dense study conducted by Prof. Dr. Mike K.S. Chan and Prof. Dr. Michelle B.F. Wong, with the support of a professional team of researchers, highlights how important is to delve deeper into the study of the thymus gland which plays a crucial role in immune system health. As we read in the forewords the topics presented are the results of a collaboration between experts coming from various fields such as immunology, gerontology, regenerative medicine, and clinical practice. This comprehensive book can strengthen the communication and collaboration among these disciplines, fostering a more holistic approach to addressing age-related health challenges. Bioregenerative medicine in general, and Thymic regeneration therapies are an important part of the daily medical practice. THYMUS THERAPY represents a pivotal study and another scientific milestone that puts once again Prof. Chan and his Team at the forefront worldwide. Prof. Dato Sri Dr. Mike K.S. Chan, is a pioneer of Cellular, Organo and Cell Membrane Therapies in Europe and Asia since the early 1980’s. He founded one of the world’s largest research groups of Bio-Molecular Medicine based in Switzerland and Germany with a global presence in almost eighty countries. He has conducted more than 1,000 lectures, seminars, and symposiums worldwide in the fields of antiaging, cell regeneration, bio-regenerative medicine, and stemcell therapies. Author & co-author of numerous books and articles in the fields of cell therapy, immunology, bio-regenerative sciences, nutrition, and innovator of cellular based nutraceuticals & cosmeceuticals, Prof. Mike Chan is also the founder of European Wellness Biomedical Group—an International chain of research and treatment facilities (European Wellness Centers & Retreats) involved in anti-aging, longevity and education (European Wellness Academy). He chairs and also sits on board on numerous prominent antiaging and cell therapy associations of the world. Prof. Dato Sri Dr. Michelle Wong Bi Fah, ND, PhD is a scientist, researcher and educator actively involved in research and development (R&D) work on stem cells focusing on Fetal Precursor Stem-Cell Therapy. She is the Co-Founder/Senior Technical Advisor and Researcher in FCTI Inc., specialising in Stem cell Research and Bio-Regenerative Medicine for more than three decades. A prominent speaker, Michelle Wong presents at educational programs and global conferences on stem cells, cell therapy and biological medicine for physicians and healthcare practitioners worldwide.

Haematopoietic stem cell transplantation was initiated in the early 1970’s by pioneers studying radiation-induced bone marrow damage and blood transfusion. Since that time there have been over one million transplants and over 34 million donors registered with the world marrow donor association. This special edition of Frontiers in Immunology highlights the research achievements which led to the curative therapy of haematopoietic stem cell transplantation (HSCT) but also reviews the ongoing complications such as graft versus host disease (GvHD) and infection caused by the procedure. Early animal and human studies are reviewed as well as those which led to the development of changes in transplant protocols such as peripheral blood stem cell and cord blood transplants and the harnessing of graft versus leukaemia (GvL) effects by donor lymphocyte infusions. The eBook covers immunogenetics, the role of biomarkers, and future developments of the therapy which will aim to further improve the outcome for HSCT patients. The eBook is divided into 8 chapters dealing with animal studies; a history of early human studies; the pathophysiology of HSCT; graft versus host disease; graft versus leukaemia effects; immune reconstitution; non-HLA immunogenetics and future developments, including use of mesenchymal stem cells, virus specific T cells and chimeric antigen receptor (CAR) therapy.

Human Cell Membrane Therapy explores the theoretical and practical dimensions of improving service provision on majority of the diseases caused by cell damage. This readable and well-structured book is based on the reviews of current scientific publications on cellular membranes, its chemical structure and changes in many diseases.

Written by known specialists in the field, this is a comprehensive and timely overview of a central and expanding topic. Simultaneously an introduction and a description of the latest concepts, findings and methods, the handbook provides basic knowledge on technical issues required for those intending to research in the field. It covers the functional role of involved molecules and the cellular mechanisms, and addresses selected examples for their possible application in therapy -- bridging the gap between trafficking mechanisms and novel therapeutic strategies. In addition, it includes selection of proven and timesaving methods for studying cell trafficking in vitro and in vivo. The accompanying CD-ROM makes leukocyte migration videos available to a broad audience for the first time.

The discovery of insulin at the University of Toronto in 1921-22 was one of the most dramatic events in the history of the treatment of disease. Insulin was a wonder-drug with ability to bring patients back from the very brink of death, and it was no surprise that in 1923 the Nobel Prize for Medicine was awarded to its discoverers, the Canadian research team of Banting, Best, Collip, and Macleod. In this engaging and award-winning account, historian Michael Bliss recounts the fascinating story behind the discovery of insulin – a story as much filled with fiery confrontation and intense competition as medical dedication and scientific genius. Originally published in 1982 and updated in 1996, The Discovery of Insulin has won the City of Toronto Book Award, the Jason Hannah Medal of the Royal Society of Canada, and the William H. Welch Medal of the American Association for the History of Medicine.